All GLG News Analyses Filed Under: Business of Medicine
Posted November 13, 2008CVS Escalates the Generic Price War
Analysis of: CVS joins generic drug price war | www.upi.com
Author: Adam Fein, Founder & President Pembroke Consulting Inc
CVS Caremark (CVS) launched its new Health Savings Pass, which allows customers to buy 90 day supplies of over 400 generics for $9.99 (after paying an enrollment fee of $10). The new program sounds like a logical pre-emptive strike against anticipated share losses. Translation: an old-fashioned, race-to-the-bottom...
Posted November 13, 2008
Economy's impact on healthcare facilities
Analysis of: Hospitals See Drop in Paying Patients | www.nytimes.com
Author: James Leonard, Chief Information Officer The Regional Medical Center at Memphis
Economy's impact on healthcare facilities
Analysis of: Hospitals See Drop in Paying Patients | www.nytimes.com
Author: James Leonard, Chief Information Officer The Regional Medical Center at Memphis
Significant decline scheduled procedures. Greater activity in Emergency Room combined with increase in uninsured and underinsured patients. A difficult outlook for Acute care facilities.
Posted November 12, 2008
Science vs Marketing
Analysis of: Pharma need not worry too much about President Obama | www.pharmatimes.com
Author: GLG Member Program Contributor
Analysis of: Pharma need not worry too much about President Obama | www.pharmatimes.com
Author: GLG Member Program Contributor
The Obama vision is based on science driving the prescription process. As such, DTC advertising and the sampling of brand name medications will either be restricted or incentives provided to MDs to replace samples with vouchers. PBMs will be required to be absolutely transparent and Medicare...
Posted November 12, 2008
Many Key Healthcare Players Will See Drop
Analysis of: Hospitals See Drop in Paying Patients | www.nytimes.com
Author: GLG Member Program Contributor
Analysis of: Hospitals See Drop in Paying Patients | www.nytimes.com
Author: GLG Member Program Contributor
Not just hospitals, but many players will see receivables drop including wellness and disease management companies, imaging diagnostics and labs, and soon manufacturers.
Posted November 10, 2008
Expect Costs to Rise as Producers React
Analysis of: Bush Signs Drug Safety Bill Into Law | www.usatoday.com
Author: John Wilkerson, Executive Director Bellwether Logistics Services, LLC
Expect Costs to Rise as Producers React
Analysis of: Bush Signs Drug Safety Bill Into Law | www.usatoday.com
Author: John Wilkerson, Executive Director Bellwether Logistics Services, LLC
The law is needed and necessary. Technology may not be the best solution in every case.
Posted November 10, 2008
Big Pharma will continue to thrive in new administration, but not insurnace companies
Analysis of: Pharma need not worry too much about President Obama | www.pharmatimes.com
Author: GLG Member Program Contributor
Analysis of: Pharma need not worry too much about President Obama | www.pharmatimes.com
Author: GLG Member Program Contributor
President elect Obama will try , most probably unsuccessfully, to take on insurance companies in orfder to fulfill his election promises of "close to universal" health care.
Generics will thrive, but Big Phrama , especially those with innovative products and biotech companies will continue to pr...
Posted November 10, 2008
President Obama Could be Santa Claus for Health IT Companies
Analysis of: Healthcare Tech Companies Could Benefit from Obama Plan | money.cnn.com
Author: GLG Member Program Contributor
Analysis of: Healthcare Tech Companies Could Benefit from Obama Plan | money.cnn.com
Author: GLG Member Program Contributor
President-Elect Obama made reforming the U.S. healthcare system a central plank of his campaign. A key initiative calls for spending $10 billion a year over the next five years ($50 billion total) to computerize health records and prescribe more treatments digitally.
Posted November 10, 2008
Is Pharma's Head in the Sand??
Analysis of: Pharma need not worry too much about President Obama | www.pharmatimes.com
Author: GLG Member Program Contributor
Analysis of: Pharma need not worry too much about President Obama | www.pharmatimes.com
Author: GLG Member Program Contributor
The implication is that our new chief executive has "bigger fish to fry" than attaching drug costs??
Posted November 6, 2008New Details on WMT-CAT Pharmacy Deal
Analysis of: Caterpillar/Wal-Mart Rx Drug Pilot Scraps Use of Average Wholesale Price, Uses Drug Cost-Plus Pricing | www.aishealth.com
Author: Adam Fein, Founder & President Pembroke Consulting Inc
A just-published article in Drug Benefit News provides new details about the Wal-Mart’s (WMT) $0 generic co-pay program with Caterpillar (CAT). Anyone involved in the pharmacy channel – pharmacies, pharmacy benefit managers (PBMs), insurers, payers, drug wholesalers – should be paying attention to the...
Posted November 6, 2008
GSK to cut sales force , but......
Analysis of: Glaxo Plans 12% Reduction in Its U.S. Drug Sales Force | online.wsj.com
Author: GLG Member Program Contributor
Previous
Page :
1 2 3 4 5 6 7 8 9 10 11 12 Next21 to
30
of 649Analysis of: Glaxo Plans 12% Reduction in Its U.S. Drug Sales Force | online.wsj.com
Author: GLG Member Program Contributor
"As part of the restructuring, the company plans to group its sales staff around specific treatment areas" including oncology, probably
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Why the doctor can't see you now
seattlepi.nwsource.com
Johnson & Johnson buys medical device maker
www.nytimes.com
Potassium loss from blood pressure drugs may explain higher risk of adult diabetes
www.fiercebiotech.com
McKesson Agrees To Settlement In Pricing Suits
online.wsj.com
Use of Antipsychotics in Children Poses Risks of Adverse Effects
November 26, 2008
Avastin and clots? News to me. Black box warning? Why?
November 24, 2008
Off Label Use Can Be Prevented
November 24, 2008
Gardasil will most certainly be approved for boys
November 24, 2008
Medivations's (MDVN) Dimebon - We've Seen This Movie Before
November 24, 2008

